(firstQuint)Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis.

 Ten patients from both genders diagnosed with Knee osteoarthrosis, will be enrolled according to strict inclusion and exclusion criteria.

 These patients will be injected with Wharton Jelly derived Mesenchymal Stem Cells.

 Then, they are followed by clinical assessment, laboratory investigations as well as magnetic resonance imaging (MRI) of the injected knee.

.

 Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis@highlight

Wharton Jelly derived Mesenchymal Stem Cells (WJMSC) will be injected in patients diagnosed with Knee osteoarthrosis